FUCHS, C. S., S. AZEVEDO, T. OKUSAKA, J.-L. Van LAETHEM, L. R. LIPTON, H. RIESS, C. SZCZYLIK, M. J. MOORE, M. PEETERS, G. BODOKY, M. IKEDA, B. MELICHAR,
Radim NĚMEČEK, S. OHKAWA, A. ŚWIEBODA-SADLEJ, S. A. TJULANDIN, E. Van CUTSEM, R. LOBERG, V. HADDAD, J. L. GANSERT, B. A. BACH a A. CARRATO. A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial.
Annals of Oncology. Oxford: Oxford University Press, 2015, roč. 26, č. 5, s. 921-927. ISSN 0923-7534. Dostupné z: https://dx.doi.org/10.1093/annonc/mdv027.